Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Financing Cash Flow

₹4.08B

TTM · Period ending: · INR

RDY logo

RDY Financing Cash Flow

Latest reported₹4.08B INR
RDY TTM Cash from Financing · INR (-₹333.57M → ₹4.08B)
High-resolution chart · PNG

RDY financing cash flow history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Dr. Reddy's Laboratories Ltd Common Stock Financing Cash Flow — Trailing twelve months (TTM) (INR)
Period endingFinancing Cash Flow (INR)
4,075,413,000
9,989,413,000
-6,119,000,000
-13,306,000,000
8,167,000,000
18,911,000,000
26,282,702,447
25,763,455,571
2,577,455,571
-8,439,544,429
-12,739,246,876
-12,227,000,000
-17,537,000,000
-26,861,000,000
-17,466,000,000
-20,617,000,000
-15,483,000,000
-2,422,000,000
-7,398,437,507
-4,926,136,242
-6,279,136,242
-1,359,136,242
-1,396,564,432
-17,603,865,697
-17,018,865,697
-30,512,865,697
-36,205,000,000
-30,474,000,000
-28,833,000,000
-21,326,000,000
-21,754,000,000
-8,939,000,000
-4,537,000,000
-4,440,000,000
-5,799,000,000
-11,562,000,000
9,891,000,000
-3,692,000,000
2,541,000,000
2,803,000,000
-26,125,000,000
-17,001,000,000
-11,720,000,000
-6,808,000,000
-3,927,000,000
-4,118,000,000
-12,022,000,000
-13,172,000,000
-7,498,000,000
-217,000,000
2,607,000,000
2,455,000,000
1,063,000,000
-1,792,000,000
-6,478,000,000
-1,578,000,000
4,595,000,000
3,735,000,000
12,926,000,000
6,919,000,000
379,000,000
-377,000,000
-921,000,000
-1,695,000,000
-1,907,000,000
-5,307,000,000
-9,878,000,000
-8,528,576,000
-4,087,426,000
-2,527,000,000
-88,782,984
437,484,295
-779,861,559
-6,827,600,002
-10,813,797,346
-5,490,371,318
-6,968,861,725
1,757,851,874
31,716,252,565
25,658,681,672
26,437,531,135
27,281,303,869
1,221,410,863
2,281,417,673
1,292,932,166
1,931,309,942
1,304,447,297
451,913,720
1,436,794,701
-376,919,758
-427,906,322
-300,148,876
-183,815,649
-152,559,258
-333,570,060
-1,055,618,580
-988,267,763
1,420,197,433
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.